05 July 2023 – Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials. The acquisition provides access to Solus Biotech’s existing biotech-derived ceramide and phospholipid technologies. Located in South Korea, this expands Croda’s Asian manufacturing capability further and will create a new biotechnology R&D hub in the region.
Solus Biotech brings a portfolio of phospholipids, spanning pharmaceutical and nutraceutical applications. These naturally derived phospholipids are produced at a GMP plant and can be used as delivery systems for pharmaceutical actives.
This will strengthen the Pharma presence in Asia and enable collaborative R&D with Croda’s Avanti portfolio for the supply of lipid systems for drug delivery.
The acquisition will give Croda greater ability to serve natural phospholipids to customers in Asia and globally, and the opportunity to accelerate delivery of Croda’s pharma product innovation pipeline. To know more
